AI Analysis
AI-generated analysis. Always verify with the original filing.
Microbot Medical Inc. announced the publication of an article in the Journal of Vascular and Interventional Radiology detailing the LIBERTY ACCESS PVI Pivotal Study, with Dr. Francois Cornelis as Lead Principal Investigator. This peer-reviewed validation supports the FDA-cleared LIBERTY Endovascular Robotic System's quality and aids commercial adoption following limited market release in late 2025.
Key Takeaways
1Publication of 'In Vivo Evaluation of a Disposable Endovascular Robotic System for Arterial Peripheral Vascular Interventions: A Multicenter Feasibility Study' in JVIR on March 24, 2026.
2ACCESS PVI Pivotal Study completed in 2025 and presented at SIR annual meeting in April 2025.
3LIBERTY system received FDA clearance in September 2025 for peripheral endovascular procedures.
4Limited market release of LIBERTY commenced late 2025; full release planned at SIR conference in April 2026.